Filling the Analysis Gap in the Move to Continuous Processing

More pharmaceutical companies are becoming interested in continuous processing, but they may face an “analytics gap,” because continuous will require a different approach to analytics. The author discusses issues and best approaches for solid dosage form pharmaceuticals.

from Pharmaceutical Technology’s 2016 Solid Dosage Drug Development and Manufacturing eBook.

View other articles in the